Literature DB >> 22593617

B cell receptor-ERK1/2 signal cancels PAX5-dependent repression of BLIMP1 through PAX5 phosphorylation: a mechanism of antigen-triggering plasma cell differentiation.

Takahiko Yasuda1, Fumihiko Hayakawa, Shingo Kurahashi, Keiki Sugimoto, Yosuke Minami, Akihiro Tomita, Tomoki Naoe.   

Abstract

Plasma cell differentiation is initiated by Ag stimulation of BCR. Until BCR stimulation, B lymphocyte-induced maturation protein 1 (BLIMP1), a master regulator of plasma cell differentiation, is suppressed by PAX5, which is a key transcriptional repressor for maintaining B cell identity. After BCR stimulation, upregulation of BLIMP1 and subsequent suppression of PAX5 by BLIMP1 are observed and thought to be the trigger of plasma cell differentiation; however, the trigger that derepresses BLIMP1 expression is yet to be revealed. In this study, we demonstrated PAX5 phosphorylation by ERK1/2, the main component of the BCR signal. Transcriptional repression on BLIMP1 promoter by PAX5 was canceled by PAX5 phosphorylation. BCR stimulation induced ERK1/2 activation, phosphorylation of endogenous PAX5, and upregulation of BLIMP1 mRNA expression in B cells. These phenomena were inhibited by MEK1 inhibitor or the phosphorylation-defective mutation of PAX5. These data imply that PAX5 phosphorylation by the BCR signal is the initial event in plasma cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22593617     DOI: 10.4049/jimmunol.1103039

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.

Authors:  Clayton A White; Egest J Pone; Tonika Lam; Connie Tat; Ken L Hayama; Guideng Li; Hong Zan; Paolo Casali
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

Review 2.  Impaired B lymphopoiesis in old age: a role for inflammatory B cells?

Authors:  Richard L Riley
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Diacylglycerol kinase ζ limits B cell antigen receptor-dependent activation of ERK signaling to inhibit early antibody responses.

Authors:  Matthew L Wheeler; Matthew B Dong; Robert Brink; Xiao-Ping Zhong; Anthony L DeFranco
Journal:  Sci Signal       Date:  2013-10-15       Impact factor: 8.192

4.  Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma.

Authors:  Amit Sud; Hauke Thomsen; Giulia Orlando; Asta Försti; Philip J Law; Peter Broderick; Rosie Cooke; Fadi Hariri; Tomi Pastinen; Douglas F Easton; Paul D P Pharoah; Alison M Dunning; Julian Peto; Federico Canzian; Rosalind Eeles; ZSofia Kote-Jarai; Kenneth Muir; Nora Pashayan; Daniele Campa; Per Hoffmann; Markus M Nöthen; Karl-Heinz Jöckel; Elke Pogge von Strandmann; Anthony J Swerdlow; Andreas Engert; Nick Orr; Kari Hemminki; Richard S Houlston
Journal:  Blood       Date:  2018-09-07       Impact factor: 22.113

Review 5.  Transcription factors regulating B cell fate in the germinal centre.

Authors:  T Recaldin; D J Fear
Journal:  Clin Exp Immunol       Date:  2015-10-22       Impact factor: 4.330

6.  A Network Model to Describe the Terminal Differentiation of B Cells.

Authors:  Akram Méndez; Luis Mendoza
Journal:  PLoS Comput Biol       Date:  2016-01-11       Impact factor: 4.475

7.  Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.

Authors:  Marianna Sciortino; Maria Del Pilar Camacho-Leal; Francesca Orso; Elena Grassi; Andrea Costamagna; Paolo Provero; Wayne Tam; Emilia Turco; Paola Defilippi; Daniela Taverna; Sara Cabodi
Journal:  Sci Rep       Date:  2017-04-25       Impact factor: 4.379

8.  Syk degradation restrains plasma cell formation and promotes zonal transitions in germinal centers.

Authors:  Natalia Davidzohn; Adi Biram; Liat Stoler-Barak; Amalie Grenov; Bareket Dassa; Ziv Shulman
Journal:  J Exp Med       Date:  2020-03-02       Impact factor: 14.307

9.  IL-17A Promotes Pulmonary B-1a Cell Differentiation via Induction of Blimp-1 Expression during Influenza Virus Infection.

Authors:  Xiaohui Wang; Kongyang Ma; Miao Chen; King-Hung Ko; Bo-Jian Zheng; Liwei Lu
Journal:  PLoS Pathog       Date:  2016-01-06       Impact factor: 6.823

10.  Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer.

Authors:  Alica Linnebacher; Philipp Mayer; Nicole Marnet; Frank Bergmann; Esther Herpel; Steffie Revia; Libo Yin; Li Liu; Thilo Hackert; Thomas Giese; Ingrid Herr; Matthias M Gaida
Journal:  Cells       Date:  2019-09-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.